Abstract
Multiple protein ubiquitination events at DNA double-strand breaks (DSBs) regulate damage recognition, signaling and repair. It has remained poorly understood how the repair process of DSBs is coordinated with the apoptotic response. Here, we identified the E4 ubiquitin ligase UFD-2 as a mediator of DNA-damage-induced apoptosis in a genetic screen in Caenorhabditis elegans. We found that, after initiation of homologous recombination by RAD-51, UFD-2 forms foci that contain substrate-processivity factors including the ubiquitin-selective segregase CDC-48 (p97), the deubiquitination enzyme ATX-3 (Ataxin-3) and the proteasome. In the absence of UFD-2, RAD-51 foci persist, and DNA damage-induced apoptosis is prevented. In contrast, UFD-2 foci are retained until recombination intermediates are removed by the Holliday-junction-processing enzymes GEN-1, MUS-81 or XPF-1. Formation of UFD-2 foci also requires proapoptotic CEP-1 (p53) signaling. Our findings establish a central role of UFD-2 in the coordination between the DNA-repair process and the apoptotic response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Hoeijmakers, J.H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366–374 (2001).
Clejan, I., Boerckel, J. & Ahmed, S. Developmental modulation of nonhomologous end joining in Caenorhabditis elegans. Genetics 173, 1301–1317 (2006).
Lemmens, B.B. & Tijsterman, M. DNA double-strand break repair in Caenorhabditis elegans. Chromosoma 120, 1–21 (2011).
Bizard, A.H. & Hickson, I.D. The dissolution of double Holliday junctions. Cold Spring Harb. Perspect. Biol. 6, a016477 (2014).
Matos, J. & West, S.C. Holliday junction resolution: regulation in space and time. DNA Repair (Amst.) 19, 176–181 (2014).
Schwartz, E.K. & Heyer, W.D. Processing of joint molecule intermediates by structure-selective endonucleases during homologous recombination in eukaryotes. Chromosoma 120, 109–127 (2011).
West, S.C. et al. Resolution of recombination intermediates: mechanisms and regulation. Cold Spring Harb. Symp. Quant. Biol. 80, 103–109 (2015).
Bailly, A.P. et al. The Caenorhabditis elegans homolog of Gen1/Yen1 resolvases links DNA damage signaling to DNA double-strand break repair. PLoS Genet. 6, e1001025 (2010).
Silva, N., Adamo, A., Santonicola, P., Martinez-Perez, E. & La Volpe, A. Pro-crossover factors regulate damage-dependent apoptosis in the Caenorhabditis elegans germ line. Cell Death Differ. 20, 1209–1218 (2013).
Gartner, A., Milstein, S., Ahmed, S., Hodgkin, J. & Hengartner, M.O. A conserved checkpoint pathway mediates DNA damage--induced apoptosis and cell cycle arrest in C. elegans. Mol. Cell 5, 435–443 (2000).
Schumacher, B., Hofmann, K., Boulton, S. & Gartner, A. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr. Biol. 11, 1722–1727 (2001).
Derry, W.B., Putzke, A.P. & Rothman, J.H. Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 294, 591–595 (2001).
Schumacher, B. et al. Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 120, 357–368 (2005).
Reinke, V. et al. A global profile of germline gene expression in C. elegans. Mol. Cell 6, 605–616 (2000).
Vermezovic, J., Stergiou, L., Hengartner, M.O. & d'Adda di Fagagna, F. Differential regulation of DNA damage response activation between somatic and germline cells in Caenorhabditis elegans. Cell Death Differ. 19, 1847–1855 (2012).
Johnson, E.S., Ma, P.C.M., Ota, I.M. & Varshavsky, A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270, 17442–17456 (1995).
Koegl, M. et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635–644 (1999).
Saeki, Y., Tayama, Y., Toh-e, A. & Yokosawa, H. Definitive evidence for Ufd2-catalyzed elongation of the ubiquitin chain through Lys48 linkage. Biochem. Biophys. Res. Commun. 320, 840–845 (2004).
Hoppe, T. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. Trends Biochem. Sci. 30, 183–187 (2005).
Kuhlbrodt, K. et al. The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis. Nat. Cell Biol. 13, 273–281 (2011).
Okumura, F., Hatakeyama, S., Matsumoto, M., Kamura, T. & Nakayama, K.I. Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B contributes to neuritogenesis. J. Biol. Chem. 279, 53533–53543 (2004).
Hodgkin, J., Horvitz, H.R. & Brenner, S. Nondisjunction mutants of the nematode Caenorhabditis elegans. Genetics 91, 67–94 (1979).
Janiesch, P.C. et al. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat. Cell Biol. 9, 379–390 (2007).
Rape, M. et al. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107, 667–677 (2001).
Richly, H. et al. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 120, 73–84 (2005).
Meerang, M. et al. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat. Cell Biol. 13, 1376–1382 (2011).
Acs, K. et al. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat. Struct. Mol. Biol. 18, 1345–1350 (2011).
Dantuma, N.P. & Hoppe, T. Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends Cell Biol. 22, 483–491 (2012).
Baek, G.H., Kim, I. & Rao, H. The Cdc48 ATPase modulates the interaction between two proteolytic factors Ufd2 and Rad23. Proc. Natl. Acad. Sci. USA 108, 13558–13563 (2011).
Park, Y., Yoon, S.K. & Yoon, J.-B.B. TRIP12 functions as an E3 ubiquitin ligase of APP-BP1. Biochem. Biophys. Res. Commun. 374, 294–298 (2008).
Liu, G., Rogers, J., Murphy, C.T. & Rongo, C. EGF signalling activates the ubiquitin proteasome system to modulate C. elegans lifespan. EMBO J. 30, 2990–3003 (2011).
Shaye, D.D. & Greenwald, I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One 6, e20085 (2011).
Maréchal, A. & Zou, L. RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response. Cell Res. 25, 9–23 (2015).
Boulton, S.J. et al. BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans. Curr. Biol. 14, 33–39 (2004).
Solinger, J.A., Kiianitsa, K. & Heyer, W.D. Rad54, a Swi2/Snf2-like recombinational repair protein, disassembles Rad51:dsDNA filaments. Mol. Cell 10, 1175–1188 (2002).
Agostinho, A. et al. Combinatorial regulation of meiotic holliday junction resolution in C. elegans by HIM-6 (BLM) helicase, SLX-4, and the SLX-1, MUS-81 and XPF-1 nucleases. PLoS Genet. 9, e1003591 (2013).
O'Neil, N.J. et al. Joint molecule resolution requires the redundant activities of MUS-81 and XPF-1 during Caenorhabditis elegans meiosis. PLoS Genet. 9, e1003582 (2013).
Hofmann, E.R. et al. Caenorhabditis elegans HUS-1 is a DNA damage checkpoint protein required for genome stability and EGL-1-mediated apoptosis. Curr. Biol. 12, 1908–1918 (2002).
Horvitz, H.R. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res. 59 (Suppl.), 1701s–1706s (1999).
Schumacher, B. et al. C. elegans ced-13 can promote apoptosis and is induced in response to DNA damage. Cell Death Differ. 12, 153–161 (2005).
Lee, M.H. & Schedl, T. Identification of in vivo mRNA targets of GLD-1, a maxi-KH motif containing protein required for C. elegans germ cell development. Genes Dev. 15, 2408–2420 (2001).
Doh, J.H., Jung, Y., Reinke, V. & Lee, M.-H.H. RNA-binding protein GLD-1 recognizes its multiple targets using sequence, context, and structural information to repress translation. Worm 2, e26548 (2013).
Huang, F. & Mazin, A.V. A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeutic agents in mouse xenografts. PLoS One 9, e100993 (2014).
Park, Y., Yoon, S.K. & Yoon, J.-B.B. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway. J. Biol. Chem. 284, 1540–1549 (2009).
Gudjonsson, T. et al. TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. Cell 150, 697–709 (2012).
Krona, C. et al. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 22, 2343–2351 (2003).
Carén, H., Holmstrand, A., Sjöberg, R.M. & Martinsson, T. The two human homologues of yeast UFD2 ubiquitination factor, UBE4A and UBE4B, are located in common neuroblastoma deletion regions and are subject to mutations in tumours. Eur. J. Cancer 42, 381–387 (2006).
Zage, P.E. et al. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors. Cancer 119, 915–923 (2013).
Kloppsteck, P., Ewens, C.A., Förster, A., Zhang, X. & Freemont, P.S. Regulation of p97 in the ubiquitin-proteasome system by the UBX protein-family. Biochim. Biophys. Acta 1823, 125–129 (2012).
Bergink, S. et al. Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52 interaction. Nat. Cell Biol. 15, 526–532 (2013).
Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71–94 (1974).
Zeiser, E., Frøkjær-Jensen, C., Jorgensen, E. & Ahringer, J. MosSCI and gateway compatible plasmid toolkit for constitutive and inducible expression of transgenes in the C. elegans germline. PLoS One 6, e20082 (2011).
Praitis, V., Casey, E., Collar, D. & Austin, J. Creation of low-copy integrated transgenic lines in Caenorhabditis elegans. Genetics 157, 1217–1226 (2001).
Timmons, L. & Fire, A. Specific interference by ingested dsRNA. Nature 395, 854 (1998).
Gumienny, T.L., Lambie, E., Hartwieg, E., Horvitz, H.R. & Hengartner, M.O. Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 126, 1011–1022 (1999).
Hengartner, M.O., Ellis, R.E. & Horvitz, H.R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494–499 (1992).
Franz, A. et al. CDC-48/p97 coordinates CDT-1 degradation with GINS chromatin dissociation to ensure faithful DNA replication. Mol. Cell 44, 85–96 (2011).
Lans, H. et al. DNA damage leads to progressive replicative decline but extends the life span of long-lived mutant animals. Cell Death Differ. 20, 1709–1718 (2013).
Stout, G.J. et al. Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism. Mol. Syst. Biol. 9, 679 (2013).
Pourkarimi, E., Greiss, S. & Gartner, A. Evidence that CED-9/Bcl2 and CED-4/Apaf-1 localization is not consistent with the current model for C. elegans apoptosis induction. Cell Death Differ. 19, 406–415 (2012).
Gönczy, P. et al. Dissection of cell division processes in the one cell stage Caenorhabditis elegans embryo by mutational analysis. J. Cell Biol. 144, 927–946 (1999).
Hoogewijs, D., Houthoofd, K., Matthijssens, F., Vandesompele, J. & Vanfleteren, J.R. Selection and validation of a set of reliable reference genes for quantitative sod gene expression analysis in C. elegans. BMC Mol. Biol. 9, 9 (2008).
Lewis, J.A. & Fleming, J.T. Basic culture methods. Methods Cell Biol. 48, 3–29 (1995).
Spitzer, M., Wildenhain, J., Rappsilber, J. & Tyers, M. BoxPlotR: a web tool for generation of box plots. Nat. Methods 11, 121–122 (2014).
Acknowledgements
We thank Y. Kohara (National Institute of Genetics, Shizuoka, Japan), the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resources), the Bloomington Stock Center, M. Vidal (Dana-Farber Cancer Institute), Addgene and Geneservice Ltd for antibodies, plasmids, cDNAs and strains. We thank K. Gödderz, A. Lisowski and E. Stellbrink for technical help. We thank A. Franz and A. Gutschmidt for critical reading of the manuscript. We thank K. Ramadan (CRVK/MRC Oxford Institute for Radiation Oncology) and Y. Shiloh (David and Inez Myers Laboratory for Cancer Genetics) for insightful discussions on the project and for exchange of unpublished results. This work was supported by a Wellcome Trust Senior Research award (090944/Z/09/Z) to A.G.; grants from the German-Israeli Foundation (GIF 1104-68.11/2010), the Deutsche Forschungsgemeinschaft (EXC 229, SFB 829, SFB 670 and KFO 286), the European Research Council (ERC Starting Grant 260383), Marie Curie Actions (FP7 ITN CodeAge 316354, aDDRess 316390 and MARRIAGE 316964) and the Bundesministerium für Forschung und Bildung (Sybacol FKZ0315893A-B) to B.S.; and the Deutsche Forschungsgemeinschaft (EXC 229, HO 2541/8-1 and KFO 286) and the European Research Council (consolidator grant 616499) to T.H. In addition, this work was supported by COST Action (PROTEOSTASIS BM1307), supported by COST (European Cooperation in Science and Technology).
Author information
Authors and Affiliations
Contributions
L.A. and M.S. designed, performed and analyzed the experiments. W.P. performed in vitro ubiquitination assays. É.K. generated anti-ATX-3. A.G. and B.S. designed and performed the RNAi screen. B.S. and T.H. supervised the design and data interpretation. L.A., B.S. and T.H. wrote the manuscript. All authors discussed the results and commented on the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 Cell-cycle arrest and developmental and physiological apoptosis are functional in ufd-2-deleted worms.
(a) Developmental apoptosis in head region of newly hatched L1 larvae of indicated genotypes. Data show means ± s.e.m. of 3 independent experiments. n = 38 animals for ced-1(e1735) and n = 33 animals for ced-1(e1735);ufd-2(tm1380). n.s. not significant in two-tailed Student’s t-test. (b) Physiological apoptosis in pachytene region of day 1 adults of indicated genotypes. Data show means ± s.e.m. of 3 independent experiments. n varied from 44-45 animals, see Supplementary Table 2. The triple asterisk indicates P values of ≤ 0.0001 in two-tailed Student’s t-test, n.s. not significant. (c) Representative DIC images of cell cycle arrest in mitotic region of germlines of indicated genotypes 16 hrs after IR treatment(60 Gy). Filled arrowheads mark enlarged arrested mitotic cells. Representative images of 3 independent experiments. (d) Quantification of cell cycle arrest in mitotic region of germlines 16 hrs after IR treatment (60 Gy). Data show means ± s.e.m. of 3 independent experiments. n varied from 23-33 animals, see Supplementary Table 2. The triple asterisk indicates P value of ≤ 0.0001 in two-tailed Student’s t-test, n.s. not significant. (e) Autoubiquitylation of UFD-2 using UFD-2 (wild-type), UFD-2P951A, or UFD-2C448Y as ubiquitin ligases and ubiquitin (wild-type), or ubiquitin mutants that contain only one lysine for conjugation (ubiquitinonly K29, ubiquitinonly K48). Representative immunoblot of 3 independent experiments.
Supplementary Figure 2 UFD-2 forms foci late after damage induction.
(a) α-UFD-2 and α-TBG-1 western blot. Samples are lysates of wild-type, ufd-2(tm1380) and ufd-(hh1) worms. Representative immunoblot of 3 independent experiments. (b) Schematic illustration of C. elegans germline and illustrative images of a IR treated (60 Gy) germline stained with α-UFD-2 and DAPI. Two slides from a z-stack (z-slide 1 and z-slide b), one from upper and one from lower part of the germline are shown. Filled arrowheads mark nuclei positive for UFD-2 foci. Scale bar, 10 µm. (c) Quantification of UFD-2 foci in pachytene region of wild-type germlines treated with IR (0, 60 Gy) isolated 5 and 24 hrs later. Data show means of ± s.e.m. of 3 experiments. n varied from 37-61 animals, see Supplementary Table 2.
Supplementary Figure 3 UFD-2 forms IR-dependent foci and interacts with CDC-48.
(a) Quantification of UFD-2 foci in pachytene region of wild-type germlines 24 hrs after treatment with IR (0, 60 Gy) or UV (600 J/m2). Data show means ± s.e.m. of 3 experiments. n varied from 69-96 animals, see Supplementary Table 2. (b) Embryonic survival after IR treatment (0, 30 or 60 Gy). Data show means ± s.e.m. of five experiments. n varied from 75-147 animals, see Supplementary Table 2. The single, double and triple asterisks indicate P values of ≤ 0.05, 0.001, 0.0001 in two-tailed Student’s t-test. (c) Representative images of worm germlines of indicated genotypes stained with α-ATX-3 antibody and DAPI 24 hrs after IR treatment (60 Gy). Scale bar, 5 µm. Representative images of 3 independent experiments. (d) α-ATX-3 and α-TBG-1 western blot. Samples are lysates of wild-type and atx-3(gk193) worms. Representative immunoblot of 3 independent experiments. (e) Quantification of number of UFD-2 foci that co-localize with ubiquitin in wild-type germlines 24 hrs after IR treatment (60 Gy). Data show means ± s.e.m. of 3 experiments. n = 32 animals. (f) Sequence alignment shows UFD-2 from C. elegans and other species, the conserved residue C448 is highlighted. (g) in vivo co-immunoprecipitation of CDC-48 with UFD-2 from indicated worm lysates. Representative immunoblot of 3 independent experiments. (h) in vitro co-immunoprecipitation of CDC-48 with UFD-2 with purified recombinantly expressed protein. Representative immunoblot of 3 independent experiments. (i) Autoubiquitylation of UFD-2 using UFD-2 (wild-type), UFD-2P951A or UFD-2C448Y as ubiquitin ligases. Representative immunoblot of 3 independent experiments. (j) Quantification of UFD-2 foci in pachytene region of indicated germlines 24 hrs after IR treatment (0, 60 Gy). Data show means of ± s.e.m. of three experiments. n varied from 40-43 animals, see Supplementary Table 2. (k) Quantification of ubiquitin foci in pachytene region of indicated germlines 24 hrs after IR treatment (60 Gy). Data show means of ± s.e.m. of three experiments. n varied from 41-45 animals, see Supplementary Table 2.
Supplementary Figure 4 Apoptosis induction in ufd-2-deleted worms is functional.
(a) Representative images of worm germlines of indicated genotypes stained with α-UFD-2 antibody and DAPI 24 hrs after IR treatment (60 Gy). Filled and empty arrowhead indicated nuclei positive or negative for UFD-2 foci, respectively. Scale bar, 5 µm. Representative images of 3 independent experiments. (b) α-CEP-1 and α-TBG-1 western blot of worm lysates of indicated genotypes. Representative immunoblot of 3 independent experiments and (c) corresponding quantification. (d) Relative expression levels of egl-1 target gene in wild-type and ufd-2(tm1380) worms at indicated time points after IR treatment (0 or 60 Gy). mRNA levels were normalized to 0 Gy samples. Data show means ± s.e.m. of 3 independent experiments.
Supplementary Figure 5 UFD-2 foci are dependent on apoptosis and DNA-damage signaling.
(a) Representative images of worm germlines of indicated genotypes stained with α-UFD-2 antibody and DAPI 24 hrs after IR treatment (60 Gy). Filled and empty arrowhead indicated nuclei positive or negative for UFD-2 foci, respectively. Scale bar, 5 µm. Representative images of 3 independent experiments. (b) α-UFD and α-TBG-1 western blot of worm lysates of indicated genotypes 24 hrs after IR treatment (0, 60 Gy). Representative immunoblot of 3 independent experiments. (c) Quantification of germ cells positive for RAD-51 staining of indicated genotypes 24 hrs after IR treatment (0 or 20 Gy). Data show means ± s.e.m. of 3 independent experiments. n varied from 30-33 animals, see Supplementary Table 2. n.s. not significant in two-tailed Student’s t-test.
Supplementary Figure 6 RAD-51 in DSB repair.
(a) Embryonic survival after IR treatment (0, 30 or 60 Gy) of indicated genotypes. Data show means ± s.e.m. of 3 independent experiments. n varied from 90-95 animals, see Supplementary Table 2. The single asterisk indicates P value of ≤ 0.05 in two-tailed Student’s t-test. (b) Quantification of germ cells positive for RAD-51 staining of indicated genotypes 24 hrs after IR treatment (0 or 20 Gy). Data show means ± s.e.m. of 3 independent experiments. n varied from 35-48 animals, see Supplementary Table 2. The single and double asterisks indicate P values of ≤ 0.05 and 0.001 in two-tailed Student’s t-test. (c) Embryonic survival after IR treatment (0, 30 or 60 Gy) of indicated genotypes treated with rad-51 or control RNAi. Data show means ± s.e.m. of one experiment, n varied from 15-25 animals, see Supplementary Table 2. The double asterisk indicates P value of ≤ 0.001 in two-tailed Student’s t-test.
Supplementary Figure 7 Full-sized images of immunoblots in figures.
(a) Presented in Figure 1e. (b) Presented in Supplementary Figure 1e. (c) Presented in Supplementary Figure 2a. (d) Presented in Supplementary Figure 3d. (e) Presented in Supplementary Figure 3g. (f) Presented in Supplementary Figure 3h. (g) Presented in Supplementary Figure 3i. (h) Presented in Supplementary Figure 4b. (i) Presented in Supplementary Figure 5b.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 (PDF 1616 kb)
Supplementary Table 1
n values for Figures 1–6 (XLSX 13 kb)
Supplementary Table 2
n values for Supplementary Figures 1–6 (XLSX 10 kb)
Rights and permissions
About this article
Cite this article
Ackermann, L., Schell, M., Pokrzywa, W. et al. E4 ligase–specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosis. Nat Struct Mol Biol 23, 995–1002 (2016). https://doi.org/10.1038/nsmb.3296
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.3296
This article is cited by
-
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
Experimental & Molecular Medicine (2022)
-
UFD-2 is an adaptor-assisted E3 ligase targeting unfolded proteins
Nature Communications (2018)